Related Experiment Video
Updated: Jul 6, 2026
10:03
Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Biomarkers in acute cardiovascular disease
Jill Howie-Esquivel1, Megan White
1Department of Physiological Nursing, University of California, San Francisco, CA 94143, USA. jill.howie-esquivel@nursing.ucsf.edu
The Journal of Cardiovascular Nursing
|April 3, 2008
Summary
Cardiac biomarkers like troponin offer vital insights into myocardial injury and acute myocardial infarction diagnosis. Future biomarkers promise enhanced specificity and earlier detection of cardiac compromise.
Area of Science:
- Biochemistry
- Cardiology
- Clinical Diagnostics
Background:
- Cardiovascular disease affects a significant portion of the population.
- Cardiac biochemical markers provide critical insights into myocardial status.
- These markers are essential for diagnosing acute myocardial infarction.
Purpose of the Study:
- To review current and emerging cardiac biomarkers in acutely ill patients.
- To discuss the advantages and disadvantages of cardiac biomarkers in clinical practice.
- To highlight the role of biomarkers in diagnosis, therapy selection, and prognosis.
Main Methods:
- Review of existing literature on cardiac biomarkers.
- Analysis of clinical utility of established markers (e.g., troponin, creatine kinase MB, B-type natriuretic peptide).
- Discussion of emerging biomarkers and their potential applications.
Main Results:
- Current biomarkers (troponin, CK-MB) are highly sensitive and specific for myocardial injury.
- B-type natriuretic peptide indicates myocardial stretch and has prognostic value in heart failure.
- Existing markers identify injury but not the specific cause.
Conclusions:
- Serum cardiac biomarkers are indispensable in modern cardiology.
- Future biomarkers aim for improved specificity and earlier detection of myocardial damage.
- Biomarker data, combined with clinical assessment, guides patient management.
Related Concept Videos
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:30Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
01:30Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
01:30Dysrhythmias V: Evaluating Dysrhythmias
Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...